~382 spots leftby Apr 2026

Mobile Integrated Health for Heart Failure

Recruiting at 2 trial locations
RM
Overseen byRuth M. Masterson Creber, PhD, MSc, RN
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Columbia University
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial compares two methods of post-hospital care for heart failure patients: phone check-ins by a care coordinator and home visits by paramedics with video doctor consultations. The goal is to see which method better reduces hospital readmissions and improves patient quality of life.

Do I have to stop taking my current medications for this trial?

The trial protocol does not specify whether you need to stop taking your current medications. It seems likely that you can continue your medications, but you should confirm with the trial coordinators.

What data supports the idea that Mobile Integrated Health for Heart Failure is an effective treatment?

The available research shows that Mobile Integrated Health can effectively reduce hospital readmissions for heart failure patients. For example, the MIGHTy-Heart study aims to compare the effectiveness of Mobile Integrated Health and telehealth in supporting patients after they leave the hospital. Additionally, a study on transition management services found that hospital readmission rates decreased from 17.9% to 8.0% after implementing these services, which are similar to Mobile Integrated Health. This suggests that Mobile Integrated Health can help keep heart failure patients healthier and out of the hospital.12345

What safety data exists for Mobile Integrated Health for Heart Failure?

The research indicates that Mobile Integrated Health (MIH) and related models like Community Paramedicine and Transitional Care aim to improve care coordination and reduce hospital readmissions for heart failure patients. These models focus on continuous management and communication across care settings, which can potentially reduce adverse events associated with poor care transitions. However, specific safety data for these interventions is not detailed in the provided research, suggesting a need for further studies to evaluate their safety comprehensively.678910

Is Mobile Integrated Health a promising treatment for heart failure?

Yes, Mobile Integrated Health is a promising treatment for heart failure. It can improve patient care, reduce hospital readmissions, and fill gaps in local healthcare by using emergency medical services in new ways. This approach helps patients manage their condition better at home, which can lead to fewer hospital visits and better overall health outcomes.29111213

Research Team

LS

Leah Shafran Topaz, BPT, MSc

Principal Investigator

Weill Medical College of Cornell University

RM

Ruth M. Masterson Creber, PhD, MSc, RN

Principal Investigator

Columbia University

Eligibility Criteria

This trial is for Medicare or Medicaid recipients with heart failure in NYC (Manhattan, Brooklyn, Queens, Bronx) who are getting out of the hospital. It's not for those who don't speak English, Spanish, Mandarin, or French; have dementia/psychosis; will go to/receive care from a nursing facility/rehab/hospice; or await a heart transplant/LVAD.

Inclusion Criteria

Live in NYC
I am currently receiving care at NewYork Presbyterian or Mount Sinai.
I receive Medicare or Medicaid benefits.
See 1 more

Exclusion Criteria

I will be, or am currently living in, a skilled nursing facility or rehab center.
Current left ventricular assist device (LVAD)
I am on the waiting list for a heart transplant.
See 3 more

Treatment Details

Interventions

  • Mobile Integrated Health (Procedure)
  • Transitions of Care Coordinator (Behavioural Intervention)
Trial OverviewThe study compares two post-hospitalization care methods: phone check-ins by a Transitions of Care Coordinator and at-home medical services by Mobile Integrated Health with community paramedics and video calls with doctors. The goal is to see which method better reduces hospital readmissions and improves life quality within 30 days after discharge.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Integrated Health (MIH)Experimental Treatment1 Intervention
Patients with urgent medical needs are seen and treated in the home by trained community paramedics. The community paramedics perform a standardized assessment, including a physical examination, vital signs, home safety evaluation, and medication reconciliation. During the MIH encounter, the emergency medicine physician at each site is contacted via telemedicine. Physicians can access clinical notes, discharge summaries, and medication lists via the institutional EHR. Adjustments to outpatient medications can be e-prescribed and follow-up appointments can be scheduled with primary care clinicians.
Group II: Transitions of care coordinator (TOCC)Active Control1 Intervention
Patients receive a follow-up phone calls for a nurse coordinator within 48-72 hours of hospital discharge. Phone calls include clinical/social needs assessment with escalation to primary care team, emergency care, or social work as needed; patient education; and reminder about follow-up appointments.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Columbia University

Lead Sponsor

Trials
1,529
Recruited
2,832,000+

Weill Medical College of Cornell University

Lead Sponsor

Trials
1,103
Recruited
1,157,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+

Findings from Research

Implementing multicomponent transition management (TM) services within a Patient Centered Medical Home (PCMH) model significantly reduced the 30-day hospital readmission rate from 17.9% to 8.0% among 118 patients.
The average time to hospital readmission was extended from 95 days to 115 days, indicating that integrated care coordination can improve patient outcomes after hospital discharge.
Impact of an integrated transition management program in primary care on hospital readmissions.Farrell, TW., Tomoaia-Cotisel, A., Scammon, DL., et al.[2016]
The MIGHTy-Heart study is a large-scale trial involving 2100 heart failure patients, comparing two postdischarge interventions: mobile integrated health (MIH) with community paramedic home visits and telehealth support, and transitions of care coordinators (TOCC) with follow-up calls from registered nurses.
The primary outcomes of the study focus on reducing 30-day hospital readmissions and improving quality of life, aiming to enhance patient care during the critical transition from hospital to home.
Using Mobile Integrated Health and telehealth to support transitions of care among patients with heart failure (MIGHTy-Heart): protocol for a pragmatic randomised controlled trial.Masterson Creber, RM., Daniels, B., Munjal, K., et al.[2022]
Despite improvements from health care reform, significant inefficiencies and communication gaps remain, particularly affecting patients with multiple chronic conditions during transitions of care.
Mobile Integrated Healthcare is a promising new model that utilizes a physician-led interprofessional team to provide continuous, on-site care management, aiming to improve health outcomes and reduce costs for these vulnerable patients.
An Innovative Approach to Health Care Delivery for Patients with Chronic Conditions.Clarke, JL., Bourn, S., Skoufalos, A., et al.[2018]

References

Impact of an integrated transition management program in primary care on hospital readmissions. [2016]
Using Mobile Integrated Health and telehealth to support transitions of care among patients with heart failure (MIGHTy-Heart): protocol for a pragmatic randomised controlled trial. [2022]
An Innovative Approach to Health Care Delivery for Patients with Chronic Conditions. [2018]
Exploring Transitional Care: Evidence-Based Strategies for Improving Provider Communication and Reducing Readmissions. [2020]
Implementation of a comprehensive program to improve coordination of care in an urban academic health care system. [2018]
The effect of a mobile integrated health program on health care cost and utilization. [2022]
Heart failure management across the continuum: a communication link. [2007]
The GeriPACT Initiative to Prevent All-Cause 30-Day Readmission in High Risk Elderly. [2021]
Transitional Care to Reduce Heart Failure Readmission Rates in South East Asia. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
Cost-Effectiveness of Transitional Care Services After Hospitalization With Heart Failure. [2020]
11.United Statespubmed.ncbi.nlm.nih.gov
Factors Associated With Successful Enrollment in a Community Paramedicine Program for Heart Failure. [2023]
12.United Statespubmed.ncbi.nlm.nih.gov
Reducing Hospital Admissions for Patients with Heart Failure by Implementing the Chronic Care Management Framework: A Cost, Quality and Satisfaction Improvement Project. [2022]
13.United Statespubmed.ncbi.nlm.nih.gov
Mobile Integrated Health Care and Community Paramedicine: An Emerging Emergency Medical Services Concept. [2018]